Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3
about
Pharmacogenomics discovery and implementation in genome-wide association studies eraPharmacogenomics of adverse drug reactionsProgress in understanding the genomic basis for adverse drug reactions: a comprehensive review and focus on the role of ethnicityUse of bisphosphonates and the risk of osteonecrosis among cancer patients: a systemic review and meta-analysis of the observational studies.Risk factors and indices of osteomyelitis of the jaw in osteoporosis patients: results from a hospital-based cohort study in Japan.Osteonecrosis of the jaw (ONJ): diagnosis and management in 2015.Bioinformatics analyses of differentially expressed genes associated with bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma.Relating human genetic variation to variation in drug responses.Population pharmacokinetic and pharmacodynamic modeling for assessing risk of bisphosphonate-related osteonecrosis of the jaw.Osteonecrosis of the jaw in patients treated with denosumab for metastatic tumors to the bone: A series of thirteen patients.Oral bisphosphonate related osteonecrosis of the jaw: a challenging adverse effectThe future of pharmacogenetics for osteoporosis.Periodontal Disease, Dental Implants, Extractions and Medications Related to Osteonecrosis of the Jaws.Genetic and acquired factors influencing the effectiveness and toxicity of drug therapy in osteoporosis.Osteonecrosis of the Jaw-a Bone Site-Specific Effect of Bisphosphonates.Biomarkers for Bisphosphonate-Related Osteonecrosis of the Jaw.Identifying a combined biomarker for bisphosphonate-related osteonecrosis of the jaw.16p11.2 600 kb Duplications confer risk for typical and atypical Rolandic epilepsy.Conservative Prosthetic Rehabilitation of Medication-Related Osteonecrosis of the Jaw (MRONJ).Osteoporosis pharmacogenomics: recent insights and future perspectives.Placenta and appetite genes GDF15 and IGFBP7 are associated with hyperemesis gravidarum.
P2860
Q27001573-FB1DE861-CDAF-4AED-AC6C-823FF65451C3Q27015820-2076DBAF-25C2-4ED8-A40C-57EB8DCBCFD0Q28083100-EE3F39DA-4349-48D9-81F4-733B3BCB420EQ35033859-7E064E38-5B64-4008-9DFA-64AA0A949C5DQ35041287-1C60E78A-D453-41A1-9588-751C018A3CF2Q35818022-47BAAEBC-AA56-43AD-A92C-1909B7F5FC75Q36111799-76920E89-8B27-4405-A81E-DB0FF295E92DQ36252524-44962E11-8D11-44E9-A1DB-A11A09A4723FQ36532868-C1BAA102-805E-4145-9E87-2937D2B0C647Q36667402-98E1689F-149E-4C21-B097-2BBD63544BD5Q36899548-2AE0D437-6E87-44D2-A9B5-536D609238CCQ38097533-17B019D0-B21A-45C7-9D48-695AE9FE3AF6Q38691628-FDFFA116-6555-4373-A0E0-85353C2AC2E5Q38739527-1DC339E6-2529-47DB-A4D0-1021ADEFF29BQ38913031-14A1C866-B4AA-4FB2-B7C0-87B63E7F42BEQ39034377-AE9DE379-BF42-4CB7-992A-35A17B85961AQ47265797-EB2222D3-2021-4810-899D-23AE2898CD48Q48710057-252BB2D4-C30F-4A10-A0E6-CC6BAE8C2B50Q49858723-56EFA557-FB83-4DF9-87EF-E348136237D7Q51462132-3CAD0CB0-EA62-44BC-8700-1345241D577AQ55276810-78190769-C5B6-41EA-811B-6FA012808A34
P2860
Genomewide pharmacogenetics of bisphosphonate-induced osteonecrosis of the jaw: the role of RBMS3
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Genomewide pharmacogenetics of ...... of the jaw: the role of RBMS3
@ast
Genomewide pharmacogenetics of ...... of the jaw: the role of RBMS3
@en
type
label
Genomewide pharmacogenetics of ...... of the jaw: the role of RBMS3
@ast
Genomewide pharmacogenetics of ...... of the jaw: the role of RBMS3
@en
prefLabel
Genomewide pharmacogenetics of ...... of the jaw: the role of RBMS3
@ast
Genomewide pharmacogenetics of ...... of the jaw: the role of RBMS3
@en
P2093
P2860
P1433
P1476
Genomewide pharmacogenetics of ...... of the jaw: the role of RBMS3
@en
P2093
Aris Floratos
Athanasios I Zavras
Paola Nicoletti
Penelope K Palaska
Vassiliki M Cartsos
Yufeng Shen
P2860
P304
P356
10.1634/THEONCOLOGIST.2011-0202
P577
2012-01-20T00:00:00Z